Information for "Reduce cardiorenal chance together with sodiumglucose cotransporter2 inhibitors vs dipeptidyl peptidase4 inhibitors in people using type 2 diabetes with out aerobic as well as renal ailments A sizable worldwide observational study"
From EECH Central
Basic information
| Display title | Reduce cardiorenal chance together with sodiumglucose cotransporter2 inhibitors vs dipeptidyl peptidase4 inhibitors in people using type 2 diabetes with out aerobic as well as renal ailments A sizable worldwide observational study |
| Default sort key | Reduce cardiorenal chance together with sodiumglucose cotransporter2 inhibitors vs dipeptidyl peptidase4 inhibitors in people using type 2 diabetes with out aerobic as well as renal ailments A sizable worldwide observational study |
| Page length (in bytes) | 3,263 |
| Page ID | 1383991 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Designfuel71 (Talk | contribs) |
| Date of page creation | 08:18, 20 April 2024 |
| Latest editor | Designfuel71 (Talk | contribs) |
| Date of latest edit | 08:18, 20 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
